Potential effects of the reuse of building material on soil quality In a circular economy, building materials have a longer life cycle and are reused in innovative ways. Reusing building materials is sustainable, but can also be risky as building materials may contain contaminants such as heavy metals.
Vaccine manufacturer employee contracts poliovirus An employee of vaccine manufacturer Bilthoven Biologicals (BBio) has been infected with a poliovirus. The virus was found in a stool sample provided by the employee. The employee concerned is now in isolation.
Limited impact of incorrect data used for list of top 100 ammonia emitters On 1 November 2022, RIVM announced that its list of top-100 ammonia emitters was compiled using incorrect emission factors for some types of livestock housing. RIVM has investigated whether the erroneous data had also been used in other RIVM products.
Annual report ‘Tuberculosis in the Netherlands’ for 2021: slight increase in number of TB patients In 2021, the number of tuberculosis (TB) patients in the Netherlands rose slightly compared to the preceding year: up to 680 TB patients from 622 in 2020. However, the 2021 number was lower than the number for 2019 (754 patients).
RIVM backs Vaccination Alliance Blokhuis As of yesterday RIVM participates in the Vaccination Alliance initiated by the Dutch State Secretary, Paul Blokhuis, Other members of this Alliance include paediatricians and nurses, general
Improving integrated care requires trust, a small-scale approach and a shared vision To improve integrated care for older people, professionals and organisations need to get to know each other, build trust and better understanding.
Slightly fewer adult smokers In 2018, 22.4 per cent of the Dutch adult population indicated they were occasional smokers.
Slightly more tuberculosis patients in the Netherlands The key figures of the National Institute for Public Health and the Environment (RIVM) show that in 2018 there were 806 TB patients in the Netherlands. This is 3 percent more than in 2017 (784).
Join our HEVnet laboratory network now! Would you like to collaborate in an international laboratory network of hepatitis E virus (HEV) experts performing supranational studies and are you able to share HEV sequences in a shared reposito